Zijlstra JM - Search Results

1

18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review.

Zijlstra JM, Lindauer-van der Werf G, Hoekstra OS, Hooft L, Riphagen II, Huijgens PC. Zijlstra JM, et al. Haematologica. 2006 Apr;91(4):522-9. Haematologica. 2006. PMID: 16585017

2

Radiation therapy in early stage Hodgkin's disease: long-term results and adverse effects.

Zijlstra JM, Dressel AJ, Mens JW, Tinteren Hv, Slotman BJ, Jonkhoff AR, Huijgens PC. Zijlstra JM, et al. Hematol J. 2002;3(4):179-84. doi: 10.1038/sj.thj.6200171. Hematol J. 2002. PMID: 12189563

3

Acute renal failure due to non-Hodgkin lymphoma infiltration of the kidneys detected by ultrasonography and confirmed by positron emission tomography.

Simsek S, Oen AL, Comans EF, v d Hoeven JJ, Zijlstra J. Simsek S, et al. Clin Nephrol. 2003 May;59(5):383-7. Clin Nephrol. 2003. PMID: 12779102

4

18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma.

Zijlstra JM, Hoekstra OS, Raijmakers PG, Comans EF, van der Hoeven JJ, Teule GJ, Jonkhoff AR, v Tinteren H, Lammertsma AA, Huijgens PC. Zijlstra JM, et al. Br J Haematol. 2003 Nov;123(3):454-62. doi: 10.1046/j.1365-2141.2003.04617.x. Br J Haematol. 2003. PMID: 14617005 Free article.

5

[Radio-immunotherapy for B-cell non-Hodgkin lymphoma].

Visser OJ, Zijlstra JM, van Dongen GA, Huijgens PC. Visser OJ, et al. Among authors: zijlstra jm. Ned Tijdschr Geneeskd. 2005 Oct 15;149(42):2324-8. Ned Tijdschr Geneeskd. 2005. PMID: 16261710 Review. Dutch.

6

Radioimmunotherapy for indolent B-cell non-Hodgkin lymphoma in relapsed, refractory and transformed disease.

Visser OJ, Perk LR, Zijlstra JM, van Dongen GA, Huijgens PC, van de Loosdrecht AA. Visser OJ, et al. Among authors: zijlstra jm. BioDrugs. 2006;20(4):201-7. doi: 10.2165/00063030-200620040-00001. BioDrugs. 2006. PMID: 16831019 Review.

7

Preparation and evaluation of (89)Zr-Zevalin for monitoring of (90)Y-Zevalin biodistribution with positron emission tomography.

Perk LR, Visser OJ, Stigter-van Walsum M, Vosjan MJ, Visser GW, Zijlstra JM, Huijgens PC, van Dongen GA. Perk LR, et al. Among authors: zijlstra jm. Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1337-45. doi: 10.1007/s00259-006-0160-0. Epub 2006 Jul 11. Eur J Nucl Med Mol Imaging. 2006. PMID: 16832633

8

Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma.

Schot BW, Zijlstra JM, Sluiter WJ, van Imhoff GW, Pruim J, Vaalburg W, Vellenga E. Schot BW, et al. Among authors: zijlstra jm. Blood. 2007 Jan 15;109(2):486-91. doi: 10.1182/blood-2005-11-006957. Epub 2006 Sep 26. Blood. 2007. PMID: 17003382 Free article. Clinical Trial.

9

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.

Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, Wiseman GA, Kostakoglu L, Scheidhauer K, Buck A, Naumann R, Spaepen K, Hicks RJ, Weber WA, Reske SN, Schwaiger M, Schwartz LH, Zijlstra JM, Siegel BA, Cheson BD; Imaging Subcommittee of International Harmonization Project in Lymphoma. Juweid ME, et al. Among authors: zijlstra jm. J Clin Oncol. 2007 Feb 10;25(5):571-8. doi: 10.1200/JCO.2006.08.2305. Epub 2007 Jan 22. J Clin Oncol. 2007. PMID: 17242397

10

FDG PET in lymphoma: the need for standardization of interpretation. An observer variation study.

Zijlstra JM, Comans EF, van Lingen A, Hoekstra OS, Gundy CM, Willem Coebergh J, Bongers V. Zijlstra JM, et al. Nucl Med Commun. 2007 Oct;28(10):798-803. doi: 10.1097/MNM.0b013e3282eff2d5. Nucl Med Commun. 2007. PMID: 17728610

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

155 results

Search Page